// App-Quantinova.ai

: TARGETING NUCLEOLIN FOR IMPROVING SUSCEPTIBILITY TO CHEMOTHERAPY IN ACUTE LYMPHOBLASTIC LEUKEMIA

Researchers

Presenter

  • Yanxin Chen

Principal Investigators

  • Zhengjun Wu

  • Lingyan Wang

  • Jingjing Wen

  • Minhui Lin

  • Jianda Hu

Medical Centers

  • Department of Hematology, Institute of Hematology, Hangzhou, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Nucleolin

  • Breakpoint Cluster Region

  • Extracellular signal-regulated kinase

Drug/Treatment

  • Adriamycin injection

  • AS-1411

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved